COVID-19

Integrated immune dynamics define correlates of COVID-19 severity and antibody responses

by Heather Eberly
14 de June de 2021

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review

by Heather Eberly
14 de June de 2021

Intestinal Flora as a Potential Strategy to Fight SARS-CoV-2 Infection

by Heather Eberly
14 de June de 202114 de June de 2021

Factors associated with COVID-19-related death using OpenSAFELY

by Heather Eberly
14 de June de 2021

The SARS-CoV-2 outbreak: What we know

by Heather Eberly
14 de June de 2021

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19

by Heather Eberly
14 de June de 202114 de June de 2021

Emerging and reemerging respiratory viral infections up to COVID-19

by Heather Eberly
14 de June de 202114 de June de 2021

Enhancing immunity in viral infections, with special emphasis on COVID-19: A review

by Heather Eberly
14 de June de 202114 de June de 2021

Kaneka Americas Holding, Inc.
Probiotics Division
7979 Gateway Boulevard, Newark (CA)
94560 United States

2024 © Kaneka Americas Holding, Inc. All Rights Reserved.

Enter your information to download exclusive content. Thank you!

Enter your information to download exclusive content. Thank you!
Email*
First name*
Last name*
Company*
Country*
Department*
Consent*
- Accept Privacy policy
Phone
This field is for validation purposes and should be left unchanged.